| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |